- CEO
- Xiao Chuan Xiong
- Full Time Employees
- 3,101
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Shenzhen China
- IPO Date
- Oct 12, 2022
- Business
- Mehow Innovative Ltd. is a medical device contract development and manufacturing organization (CDMO) that provides integrated engineering, precision manufacturing, and assembly solutions for global healthcare, medical device, and life science companies. Founded in 2010 and headquartered in Shenzhen, China, the company operates primarily within the medical consumables, medical device components, and precision molding segments. Its core product and service offerings comprise respiratory health and sleep apnea management devices and subassemblies, including continuous positive airway pressure (CPAP) mask components, silicone cushions, humidification chambers, headgear interfaces, and exhalation valves; drug delivery and diabetes care systems, including continuous glucose monitoring (CGM) sensor housings, insulin pen components, wearable infusion sets, and auto-injector casings; in vitro diagnostic (IVD) consumables, microfluidic test chips, reagent cartridges, and sample handling vessels; cardiovascular and minimally invasive surgical device components, such as endoscopic structural parts, catheter connectors, and access trocars; and contract engineering services spanning high-precision mold design, liquid silicone rubber (LSR) molding, multi-shot plastic injection molding, cleanroom automated assembly, and regulatory compliance testing. In recent developments, the company has expanded its global manufacturing footprint by establishing and scaling operational capacity at its overseas production base in Malaysia, strengthening supply chain resilience for international original equipment manufacturer (OEM) clients across North America, Europe, and the Asia-Pacific region. Additionally, Mehow Innovative Ltd. has broadened its product pipeline by entering strategic development programs for next-generation GLP-1 drug delivery devices and advanced smart chronic disease management hardware, while continuing to upgrade automated production lines and high-standard cleanroom infrastructure across its manufacturing facilities.